1SHEP collaborative research group. Prevention of stroke by anti- hypertensive drug treatment in older persons with isolated systolic hypertension.- final results of the systolic hypertension in the eld- erly program (SHEP)[J]. JAMA, 1991,265(24) :3255-3264.
2Staessen JA, Fagard R, Thijs L, et al, the systolic hypertension in Europe (Syst-Eur) trial investigators. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension[J]. Lancet, 1997,350(9080) : 757-764.
3Liu L, Wang JL, Gong L, et al. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hyper- tension[J]. J Hypertens, 1998,16( 12 Pt 1) : 1823-1829.
6Aronow WS, Fieg JL, Pepine CJ, et al. ACCF/AHA 2011 ex- pert consensus document on hypertension in the elderly[J]. J Am Coll Cardiol,2011,57(20) :2037-2114.
7The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2013 ESH/ESC guidelines for the management of arterial hypertension[J\. Eur Heart J, 2013,34 (28) :2159-2219.
8ames PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the eighth Joint National Com- mittee (JNC 8) [J[JAMA, 2014,311 (5) : 507-520.
